. 2023 Jan 3;91(1):363–388. doi: 10.3233/JAD-220919

Table 2.

Biomarkers in the CSF and APOE genotype of the CM-AD and CA-AD patients. Concentration threshold for Aβ_1 - 42 was set at 640 pg/ml, for tau protein at 580 pg/mL, and for p-tau at 61 pg/mL

	Aβ	tau	p-tau	APOE
CM-AD
1	535^*	680^*	45	ɛ3/ɛ3
2	346^*	575	70^*	ɛ3/ɛ4#
3	260^*	421	50	ɛ3/ɛ4#
4	563^*	826^*	109^*	ɛ3/ɛ4#
5	414^*	419	68^*	ɛ3/ɛ3
6	226^*	423	80^*	ɛ2/ɛ4#
7	532^*	276	73^*	ɛ3/ɛ4#
8	591^*	815^*	110^*	ɛ3/ɛ4#
9	288^*	1023^*	66^*	ɛ2/ɛ3
10	444^*	349	72^*	ɛ3/ɛ4#
11	515^*	861^*	110^*	ɛ3/ɛ4#
12	422^*	250	62^*	ɛ3/ɛ4#
13	355^*	873^*	126^*	ɛ4/ɛ4##
14	588^*	372	59	ɛ2/ɛ3
15	588^*	2589^*	280^*	ɛ3/ɛ4#
16	343^*	751^*	77^*	ɛ3/ɛ4#
17	285^*	262	42	ɛ3/ɛ3
CA-AD
1	462^*	745^*	64^*	ɛ3/ɛ4#
2	307^*	609^*	Miss	ɛ3/ɛ4#
3	393^*	1266^*	70^*	ɛ3/ɛ3
4	322^*	208	28	ɛ3/ɛ3
5	291^*	999^*	136^*	ɛ3/ɛ3
6	525^*	524	76^*	ɛ3/ɛ4#
7	354^*	567	81^*	ɛ3/ɛ3
8	445^*	219	33	ɛ3/ɛ4#
9	454^*	206	22	ɛ3/ɛ3
10	516^*	110	33	ɛ3/ɛ3
11	492^*	163	41	ɛ3/ɛ3
12	418^*	250	26	ɛ3/ɛ3
13	499^*	153	45	ɛ4/ɛ4##
14	449^*	1524^*	155^*	ɛ3/ɛ3
15	546^*	491	101^*	ɛ3/ɛ3
16	447^*	146	77^*	ɛ3/ɛ3
17	552^*	660^*	66^*	ɛ3/ɛ4#
18	509^*	512	75^*	ɛ3/ɛ4#
19	504^*	572	52	ɛ3/ɛ4#
20	420^*	526	66^*	ɛ3/ɛ4#
21	410^*	2269^*	140^*	ɛ4/ɛ4##
22	432^*	454	68^*	ɛ3/ɛ4#
23	319^*	763^*	94^*	ɛ3/ɛ3
24	592^*	348	58	ɛ4/ɛ4##
25	504^*	567	84^*	ɛ3/ɛ3
26	481^*	600^*	89^*	ɛ3/ɛ3
27	400^*	376	67^*	ɛ4/ɛ4##
28	560^*	395	61	ɛ3/ɛ3
29	417^*	302	54	ɛ3/ɛ3
30	550^*	614^*	84^*	ɛ3/ɛ3

^*Abnormal concentration. #one ɛ4 allele carriers. ## two ɛ4 allele carriers. APOE, apolipoprotein E.